期刊文献+

关于短期抗甲状腺药物治疗与抗中性粒细胞胞浆抗体关系的研究

原文传递
导出
摘要 目的探讨甲状腺功能亢进症(简称甲亢)患者治疗前后抗中性粒细胞胞浆抗体(ANCA)检出情况及其与短期抗甲状腺药物治疗的关系。方法将60例初诊Graves病甲亢患者治疗前作为未治疗组(n=60),治疗后归为治疗组(n=10),40例非甲亢健康人群作为对照组(n=40)。用间接免疫荧光法(IIF)检测血清ANCA及抗核抗体(ANA)。结果 2例初诊未治疗甲亢患者ANCA-IIF阳性,10例治疗前ANCA阴性患者药物治疗6个月后及健康人群未检测出ANCA,患者与健康人群差异无统计学意义(P>0.05)。所有血清ANA均阴性。结论 ANCA与Graves病本身可能无关,以及短期抗甲状腺药物治疗可能不诱发ANCA。
出处 《中国地方病防治》 2011年第3期235-236,共2页 Chinese Journal of Control of Endemic Diseases
  • 相关文献

参考文献11

  • 1SJ Stankus, NT Johnson. Propyhhiouracil - induced hypersensitivity vasculitis presenting as respiratory failure. Chest, 1992,102:1595 - 1596.
  • 2Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propyhhiouracil therapy. Lancet, 1993,342:651 ~ 652.
  • 3Guma M, Salinas I, Reverter JL, et al. Frequency of an - tineutrophil cytoplasmic antibody in Graves disease patients treated with methimazole. The Journal of Clinical Endocrinology and Metabolism, 2003,88 (5) :2141 -2146.
  • 4Hofi Y, Afizono K, Hara S, et al. Antineutrophil cytoplasmic autoanti- bodypositive crescentic glomerulonephritis associated with thiamazole therapy. Nephron, 1996,74 (4) :734 ~ 735.
  • 5Slot MC, Links TP, Stegeman CA, et al. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long - term follow" - up study. Arthritis Rheum ,2005,53 ( 1 ) : 108 - 113.
  • 6Guma M, Salinas I, Reverter JL, et al. Frequency of antineutrophil cytoplasmic antibody in graves disease patients Treated with methimazole. The Journal of Clinical Endocrinology and Metabolism, 2003,88 (5) :2141-2146.
  • 7Wiik A. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA. APMIS, 1989,6:12 - 13.
  • 8Tanemoto M, Miyakawa H, Hanai J, et al. Myeloperoxidase - antineutrophil cytoplasmic antibody- positive crescentic glomerulonephritis complicating the course of Graves'disease:report of three adult cases. American Journal of Kidney Diseases, 1995,26:774 - 780.
  • 9Noh JY, Asari T, Hamada N, et al. Frequency of appearance of myeloperoxidase - antineutrophil cytoplasmic antibody ( MPO - ANCA) in Graves disease patients treated with propylthiouracil and the relation- ship between MPO - ANCA and clinical manifestations. Clinical Endocrinology(Oxf) ,2001,54(5) :651 -654.
  • 10Wada N, Mukai M, Kohno M, et al. Prevalence of serum anti - myeloperoxidase antineutrophil cytoplasmic antibodies ( MPO - ANCA ) in patients with Graves disease treated with pmpylthiouracil and thiamazole. Endocrine Journal ,2002,49 ( 3 ) :329 - 334.

二级参考文献7

  • 1Zhao MH, Jones SJ, Lockwood CM. Bactericidal / permeability-increasing protein (BPI) is an important antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in vasculitis. Clin Exp Immunol, 1995, 99: 49-56.
  • 2Zhao MH, Lockwood CM. Azurocidin is a novel antigen for antineutrophil cytoplasmic autoantibodies (ANCA) in systemic vascutilis. Clin Exp Immunol, 1996 , 103: 397-402.
  • 3Harper L, Cockwell P, Savage CO. Case of propylthiouracil-induced ANCA associated small vessel vasculitis. Nephrol Dial Transplant, 1998, 13: 455-458.
  • 4Miller RM, Savige J, Nassis L, et al. Antineutrophil cytoplasmic antibody (ANCA)-positive cutaneous leucocytoclastic vasculitis associated with antithyroid therapy in Graves′ disease. Australas J Dermatil, 1998, 39: 96-99.
  • 5Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum, 2000, 43: 405-413.
  • 6Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature. Clin Nephrol, 1997, 47:336-340.
  • 7赵明辉,章友康,王海燕.加强抗中性粒细胞胞浆抗体检测方法的规范化及合理应用[J].中华内科杂志,1998,37(3):149-150. 被引量:39

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部